EviSynth vs RevMan
EviSynth
evisynth.comRevMan
cochrane.orgSide by side
| Figure | EviSynth | RevMan |
|---|---|---|
| Price from | Free | £6.67/mo |
| Free plan | Yes | Yes |
| Free trial | — | Yes |
| Open source | — | — |
| Web | Yes | Yes |
| Windows | — | Yes |
| macOS | — | Yes |
| Linux | — | Yes |
| iOS | Yes | — |
| Android | Yes | — |
| Plans published | 1 | 11 |
| Spec score · Literature Review Software | 7.7 (#16) | 8.7 (#3) |
| Collaboration | Teams can invite collaborators, resolve conflicts, and track who screened each item and when. | Authors can edit different review fields concurrently and see which collaborators are currently working in a review. |
| Intended users | The maker presents the platform for researchers, including students and faculty conducting rapid or full systematic reviews. | RevMan supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. |
| Purpose | EviSynth is a platform for conducting evidence syntheses and systematic reviews. | RevMan is Cochrane’s software for producing transparent systematic reviews, guiding authors from structured data entry and analysis through result visualization. |
| Risk of bias | Built-in tools support RoB 2, ROBINS-I, and custom checklists. | The product supports Risk of Bias 2 and the previous risk-of-bias version, with templates for assessments. |
Plans
RevMan
- Cochrane author accessFree
- Cochrane author accessFree
- Practice reviewFree
- Individual student annual subscription£80 a year
- Student£80 a year
- Academic£100 a year
- Individual academic annual subscription£100 a year
- Individual standard annual subscription£130 a year
- Standard rate£130 a year
- OrganizationPriced on request
In their own words
EviSynth
EviSynth is a platform for evidence syntheses and systematic reviews, available on Android, iOS, and the web. Its screening workflow uses a language model to assess abstracts against PICO criteria and suggest inclusion or exclusion. Built-in risk-of-bias tools support RoB 2, ROBINS-I, and custom checklists. Teams can invite collaborators, resolve conflicts, and track who screened each item and when. The AI Insights tab provides summaries, keyword extraction, and bias hints. References can be imported as EndNote XML or PubMed NBIB files, and the screening interface is designed for touch-screen use on mobile devices. The maker describes access as free for academic use, with no trials or subscriptions, and says no credit card is required to start. The platform is open source and presented for researchers, including students and faculty conducting rapid or full systematic reviews. The listed academic plan includes unlimited collaborators. The homepage credits Milad Mirmoghtadaei, M.D. as developer.
RevMan
RevMan is Cochrane’s software for building systematic reviews, from structured data entry and analysis to presenting results. It supports diagnostic test accuracy, intervention, methodology, overview, prognosis, qualitative, and flexible review types. Authors can edit separate parts of a review at the same time and see who else is working on it. Analysis options include pairwise meta-analyses, sensitivity and subgroup analyses, and fixed-effects, random-effects, Mantel-Haenszel, and inverse-variance models. Built-in outputs include forest, SROC, and funnel plots, risk-of-bias assessments, and PRISMA flow diagrams. Authors can work from ready-made or custom templates and structured headings with Cochrane methodological guidance. RevMan imports study data and references from Covidence, and RIS reference imports can draw on Crossref, PubMed, or CRS. A free practice review is deleted after 30 days and permits one person, with no data export. Free access is also available to authors working on Cochrane Reviews. Individual annual plans are £80 a year for eligible students, £100 a year for eligible academics, and £130 a year for standard subscriptions; VAT applies in the EU and UK.